Aviso Financial Inc. Buys 941 Shares of Waters Co. (NYSE:WAT)

Aviso Financial Inc. boosted its holdings in shares of Waters Co. (NYSE:WAT) by 20.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,451 shares of the medical instruments supplier’s stock after purchasing an additional 941 shares during the period. Aviso Financial Inc.’s holdings in Waters were worth $2,022,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Wealthfront Advisers LLC increased its holdings in Waters by 106,144.4% during the 4th quarter. Wealthfront Advisers LLC now owns 3,087,461 shares of the medical instruments supplier’s stock valued at $1,145,386,000 after purchasing an additional 3,084,555 shares in the last quarter. State Street Corp increased its stake in shares of Waters by 1.9% in the 3rd quarter. State Street Corp now owns 2,577,733 shares of the medical instruments supplier’s stock valued at $927,700,000 after buying an additional 49,194 shares during the period. Geode Capital Management LLC increased its stake in shares of Waters by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,416,683 shares of the medical instruments supplier’s stock valued at $508,123,000 after buying an additional 16,703 shares during the period. Janus Henderson Group PLC boosted its stake in Waters by 0.7% during the 3rd quarter. Janus Henderson Group PLC now owns 885,593 shares of the medical instruments supplier’s stock worth $318,717,000 after acquiring an additional 6,256 shares during the last quarter. Finally, Principal Financial Group Inc. grew its holdings in Waters by 11.1% during the fourth quarter. Principal Financial Group Inc. now owns 728,534 shares of the medical instruments supplier’s stock valued at $270,272,000 after purchasing an additional 72,515 shares during the period. 94.01% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Waters from $380.00 to $390.00 and gave the company a “neutral” rating in a report on Thursday, March 6th. Wells Fargo & Company boosted their price objective on shares of Waters from $415.00 to $420.00 and gave the company an “overweight” rating in a report on Thursday, February 13th. Scotiabank upgraded shares of Waters from a “sector perform” rating to a “sector outperform” rating and boosted their price objective for the company from $430.00 to $450.00 in a report on Thursday, February 13th. StockNews.com lowered shares of Waters from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th. Finally, UBS Group lifted their price target on shares of Waters from $405.00 to $410.00 and gave the company a “neutral” rating in a research note on Thursday, February 13th. Eleven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $391.07.

Waters Stock Performance

NYSE WAT opened at $363.94 on Friday. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. The firm’s fifty day moving average price is $391.20 and its two-hundred day moving average price is $369.80. Waters Co. has a 1 year low of $279.24 and a 1 year high of $423.56. The firm has a market capitalization of $21.62 billion, a P/E ratio of 33.98, a price-to-earnings-growth ratio of 3.79 and a beta of 1.00.

Waters (NYSE:WAT) last released its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. As a group, research analysts anticipate that Waters Co. will post 12.86 EPS for the current year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.